http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1463520-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d269c8e41f178194d858c230c9f85e3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 1974-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1977-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1463520-A
titleOfInvention Process for the production of imidazolines
abstract 1463520 Imidazoline compounds PFIZER Ltd 5 Sept 1975 [6 Sept 1974] 39143/74 Heading C2C The invention comprises a process for preparing compounds of the formula where Q represents a group of the formula in which the free valence may be in any one of the 5-, 6-, 7- or 8-positions in the quinoxaline or quinazoline nucleus; (R<SP>1</SP>) x represents up to 3 optional substituents in any of the remaining 5-, 6-, 7- or 8-positions, each R<SP>1</SP> being a halogen atom or a C 1 -C 6 alkyl, C 1 -C 6 alkoxy or trifluoromethyl group and x being 0 to 3; and R<SP>2</SP> represents an optional substituent in either of the 2- or 3-, or 2- or 4-positions of the quinoxaline or quinazoline nucleus, respectively, R<SP>2</SP> being a hydrogen atom or a C 1 -C 6 alkyl or C 1 -C 6 alkoxy group; which comprises heating a thioureido compound of the formula wherein Q is as defined above, to produce the corresponding isothiocyanate of the formula reacting the isothiocyanate with ethylene diamine to form a #-aminoethyl thioureido compound of the formula cyclizing the #-aminoethyl-thioureido compound to form the compound of the Formula (I), recovering the latter as the product, and, optionally, converting the product into a pharmaceutically acceptable acid addition salt.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5714486-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5552403-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5703077-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7265117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5773440-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5756503-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5587376-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6323204-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5561132-A
priorityDate 1974-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411317346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414092084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457490761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457489092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7045

Total number of triples: 38.